Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Lauterbach

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Scientific Reports|March 30, 2023
Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradicationMaria Hinterberger, Kathrin Endt, Barbara Bathke, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatmentJosipa Raguz, Catarina Pinto, Theresa Pölzlbauer, et al.
The Journal of Experimental Medicine|October 27, 2010
Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly ICHenning Lauterbach, Barbara Bathke, Stefanie Gilles, et al.
Science (New York, N.Y.)|July 24, 2012
TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modificationMarina Oldenburg, Anne Krüger, Ruth Ferstl, et al.
The Journal of Infectious Diseases|August 21, 2023
Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus-Specific CD8 T-Cell Responses and High Anti-Hepatitis B Surface Antigen TitersSarah Schmidt, Meron Mengistu, Stephane Daffis, et al.
NPJ Vaccines|November 9, 2023
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeysArchana V Boopathy, Bhawna Sharma, Anurag Nekkalapudi, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:CCelia Gomar, Claudia Augusta Di Trani, Angela Bella, et al.
Oncoimmunology|January 18, 2021
Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancerSarah Schmidt, Weldy V Bonilla, Andrea Reiter, et al.
Journal of Virology|June 3, 2024
Flt3 agonist enhances immunogenicity of arenavirus vector-based simian immunodeficiency virus vaccine in macaquesArchana Vidya Boopathy, Anurag Nekkalapudi, Janette Sung, et al.
Vaccines|July 27, 2024
Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human PrimatesBhawna Sharma, Elena Bekerman, Hoa Truong, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Scientific Reports|March 30, 2023
Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradicationMaria Hinterberger, Kathrin Endt, Barbara Bathke, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatmentJosipa Raguz, Catarina Pinto, Theresa Pölzlbauer, et al.
The Journal of Experimental Medicine|October 27, 2010
Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly ICHenning Lauterbach, Barbara Bathke, Stefanie Gilles, et al.
Science (New York, N.Y.)|July 24, 2012
TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modificationMarina Oldenburg, Anne Krüger, Ruth Ferstl, et al.
The Journal of Infectious Diseases|August 21, 2023
Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus-Specific CD8 T-Cell Responses and High Anti-Hepatitis B Surface Antigen TitersSarah Schmidt, Meron Mengistu, Stephane Daffis, et al.
NPJ Vaccines|November 9, 2023
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeysArchana V Boopathy, Bhawna Sharma, Anurag Nekkalapudi, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:CCelia Gomar, Claudia Augusta Di Trani, Angela Bella, et al.
Oncoimmunology|January 18, 2021
Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancerSarah Schmidt, Weldy V Bonilla, Andrea Reiter, et al.
Journal of Virology|June 3, 2024
Flt3 agonist enhances immunogenicity of arenavirus vector-based simian immunodeficiency virus vaccine in macaquesArchana Vidya Boopathy, Anurag Nekkalapudi, Janette Sung, et al.
Vaccines|July 27, 2024
Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human PrimatesBhawna Sharma, Elena Bekerman, Hoa Truong, et al.
Pageof 4